BURNING ROCK BIOTECH LTD's ticker is BNR and the CUSIP is 12233L107. A total of 38 filers reported holding BURNING ROCK BIOTECH LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,954,968 | -55.3% | 4,077,286 | -0.9% | 0.00% | -66.7% |
| Q2 2023 | $8,844,612 | -24.1% | 4,113,773 | -0.7% | 0.00% | -25.0% |
| Q1 2023 | $11,645,613 | +21.7% | 4,144,346 | -2.6% | 0.00% | +33.3% |
| Q4 2022 | $9,571,138 | -6.8% | 4,253,839 | -1.0% | 0.00% | -25.0% |
| Q3 2022 | $10,269,000 | -20.0% | 4,296,280 | -2.6% | 0.00% | 0.0% |
| Q2 2022 | $12,834,000 | -44.7% | 4,410,552 | +76.7% | 0.00% | -42.9% |
| Q1 2022 | $23,192,000 | +10.1% | 2,496,493 | +12.9% | 0.01% | +16.7% |
| Q4 2021 | $21,072,000 | +62.9% | 2,211,094 | +205.6% | 0.01% | +50.0% |
| Q3 2021 | $12,935,000 | -2.5% | 723,473 | +60.6% | 0.00% | 0.0% |
| Q2 2021 | $13,271,000 | +9.7% | 450,430 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $12,097,000 | +96.7% | 449,303 | +68.8% | 0.00% | +100.0% |
| Q4 2020 | $6,150,000 | +1101.2% | 266,245 | +1203.1% | 0.00% | – |
| Q3 2020 | $512,000 | – | 20,431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 217,728 | $5,030,000 | 2.29% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,685,908 | $38,944,000 | 2.07% |
| Casdin Capital, LLC | 1,922,150 | $44,402,000 | 1.32% |
| Orbimed Advisors | 4,161,675 | $96,135,000 | 0.84% |
| INDUS CAPITAL PARTNERS, LLC | 144,580 | $3,340,000 | 0.52% |
| Aspex Management (HK) Ltd | 486,418 | $11,236,000 | 0.44% |
| HSG Holding Ltd | 212,121 | $4,900,000 | 0.41% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 15,100 | $349,000 | 0.39% |
| HAMILTON LANE ADVISORS LLC | 44,416 | $1,026,000 | 0.38% |
| Monashee Investment Management LLC | 80,000 | $1,848,000 | 0.24% |